01-04-2008, 05:48 PM
|
 |
Enlightener
|
� |
Join Date: Apr 2006
Posts: 781
|
|
high-dose vitamin C vs non-Hodgkin lymphoma
Quote:
�Vitamin C administered intravenously has shown great promise in the laboratory and there has been some anecdotal data in cancer patients, but no one has really ever run a detailed study on humans. Vitamin C doesn�t cost much and is very low in toxicity, making it a particularly desirable agent for further study.�
Recent research conducted by the NIH collaborators of this study has shown that when given in sufficient amounts intravenously, vitamin C converts to hydrogen peroxide. When applied to certain non-Hodgkin lymphoma cells in the laboratory, the converted hydrogen peroxide kills them while leaving the surrounding healthy cells intact.
�Previous human studies have been flawed because the vitamin C was given orally versus intravenously,� said Monti. �The problem with that is the oral route tightly limits the amount of vitamin C that can get into the bloodstream. When vitamin C is given intravenously you can get up to 70 times more of the vitamin into the blood versus the same dose given orally. It is these high blood levels that are required to get the mechanism of action, vitamin C converting to hydrogen peroxide around the cancer cells, to occur. Although other cancers could be a contender for this intervention, the preliminary data on non-Hodgkin lymphoma cells is why we decided to start with this disease.� https://www.physorg.com/news118493182.html
|
~~~~~~~~~~~~
__________________
For now we see through a glass, darkly.... 1st Corinthians 13:12
|
Linear Mode
